Radiation Therapy Oncology Group RTOG

Radiation Therapy Oncology Group RTOG R-0012 Randomized Phase II Trial of Preoperative Combined Modality Chemoradiation for Distal Rectal Cancer... 

MacDonald D. A Phase I study of Topotecan plus cranial radiation for glioblastoma multiforme a report of Radiation Therapy Oncology Group (RTOG) study 95-07. Proc Am Soc Thera Rad Oncol. Int J Radiat Oncol Biol Phys 1997 39 271. 

The Radiation Therapy Oncology Group (RTOG) has recently reported a randomized phase III trial (RTOG 9003), comparing four arms of radiotherapy for patients with locally advanced HNC (8). The four arms were as follows ... 

Fu KK, Pajak TF, Trotti A, et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas first report of RTOG 9003. lnt J Radiat Oncol Biol Phys 2000 48 7-16. 

The Radiation Therapy Oncology Group (RTOG), 1997, compared mixed beam (a combination of photons and neutrons) to conventional photons for locally advanced prostatic cancer. Loco-regional control as well as survival were significantly superior after mixed-beam irradiation (Fig. 11) [34]. 

Pilepich MV, Winter K, John MJ, et al. Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate. Int J Radiat Oncol Biol Phys 2001 50 1243-1252. 

Cooper JS, Guo MD, Herskovie A, et al. Chemoradiotherapy of locally advanced esophageal cancer long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA 1999 281(17) 1623-1627. 

Eifel PJ, Winter K, Morris M et al (2004) Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer an update of Radiation Therapy Oncology Group Trial (RTOG) 90-01. J Clin Oncol 22 872-880... 

---